A Pan-Cancer Analysis of Natriuretic Peptide Receptor 3 (NPR3) with Clinical Cohort and in vitro Validation
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Natriuretic peptide receptor 3 (NPR3) is down-regulated in most cancers and acts as a prognostic biomarker. Higher NPR3 expression in kidney cancer correlates with better survival, suggesting its potential as a therapeutic target.
Area Of Science
- Oncology
- Molecular Biology
- Biomarker Discovery
Background
- Natriuretic peptide receptor 3 (NPR3) is implicated in angiogenesis, immune regulation, and cancer progression.
- The clinical significance of NPR3 across various cancers is not well-understood.
- This study investigates NPR3's role as a prognostic biomarker, especially in kidney cancer.
Purpose Of The Study
- To comprehensively analyze the pan-cancer role of NPR3.
- To evaluate NPR3 as a prognostic biomarker in kidney cancer.
- To explore NPR3's potential as a therapeutic target.
Main Methods
- Utilized 20 databases for pan-cancer analysis, including differential expression, ceRNA, and PPI network analyses.
- Performed survival analysis, correlation assessments with clinical/genomic/immune features, and drug sensitivity analysis.
- Conducted immunohistochemistry on kidney neoplasms and in vitro experiments to validate NPR3's function.
Main Results
- NPR3 is down-regulated in most cancer types and associated with prognosis, tumor purity, immunity, and drug sensitivity.
- In kidney neoplasms, lower NPR3 expression correlated with poorer outcomes (OS and PFS).
- NPR3 knockdown inhibited proliferation and migration in renal cancer cells.
Conclusions
- NPR3 functions as a prognostic and immunotherapeutic biomarker in pan-cancer.
- Further research is needed to elucidate NPR3's biological functions and therapeutic potential.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Receptor tyrosine kinases:
Receptor tyrosine kinases (RTKs) phosphorylate specific tyrosines on the signaling proteins. RTKs include various growth factor receptors,...